Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10048)
All Articles published online
|
Publishing Process of This Article
|
Mar 27, 2015 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nard FD, Todoerti M, Grosso V, Monti S, Breda S, Rossi S, Montecucco C, Caporali R. Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs. World J Hepatol 2015; 7(3): 344-361 [PMID: 25848463 DOI: 10.4254/wjh.v7.i3.344] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i3/344.htm |
| Number | Citing Articles |
| 1 |
M. Elaine Husni. Comorbidities in Psoriatic Arthritis. Rheumatic Disease Clinics of North America 2015; 41(4): 677 doi: 10.1016/j.rdc.2015.07.008
|
| 2 |
Marco Sebastiani, Fabiola Atzeni, Laura Milazzo, Luca Quartuccio, Carlo Scirè, Giovanni Battista Gaeta, Giovanni Lapadula, Orlando Armignacco, Marcello Tavio, Ignazio Olivieri, Pierluigi Meroni, Laura Bazzichi, Walter Grassi, Alessandro Mathieu, Claudio Mastroianni, Evangelista Sagnelli, Teresa Santantonio, Caterina Uberti Foppa, Massimo Puoti, Loredana Sarmati, Paolo Airò, Oscar Massimiliano Epis, Rossana Scrivo, Miriam Gargiulo, Agostino Riva, Andreina Manfredi, Giovanni Ciancio, Gianguglielmo Zehender, Gloria Taliani, Luca Meroni, Salvatore Sollima, Piercarlo Sarzi-Puttini, Massimo Galli. Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne. Revue du Rhumatisme 2018; 85(2): 115 doi: 10.1016/j.rhum.2017.09.001
|
| 3 |
Stefano Piaserico, Francesco Messina, Francesco Paolo Russo. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations. American Journal of Clinical Dermatology 2019; 20(6): 829 doi: 10.1007/s40257-019-00457-3
|
| 4 |
Rajesh Gopalarathinam, Mais Arwani, Mary Chester M. Wasko, Tarun S. Sharma. Comorbidity in Rheumatic Diseases. 2017; : 1 doi: 10.1007/978-3-319-59963-2_1
|
| 5 |
İlkay BOZKURT, Ahmet BEKTAŞ. Anti-TNF alfa kullanan hastalarda hepatit B reaktivasyonunun değerlendirilmesi. Dicle Tıp Dergisi 2019; 46(3): 553 doi: 10.5798/dicletip.620594
|
| 6 |
Wiebke Kathmann. Rheuma und Infektionen. Orthopädie & Rheuma 2016; 19(2): 15 doi: 10.1007/s15002-016-0866-8
|
| 7 |
Sultan M. Almogairen. Abatacept induced granulomatous hepatitis with a sarcoidosis- like reaction: a blinded trial in mice. BMC Pharmacology and Toxicology 2019; 20(1) doi: 10.1186/s40360-019-0303-0
|
| 8 |
Asako Tagawa. Infectious issues of therapeutic monoclonal antibodies in multiple sclerosis and neuromyelitis optica spectrum disorders. Clinical and Experimental Neuroimmunology 2022; 13(3): 143 doi: 10.1111/cen3.12721
|
| 9 |
Ioanna G. Saougou, Theodora E. Markatseli, Paraskevi V. Voulgari, Alexandros A. Drosos. Current Therapeutic Options for the Treatment of Juvenile Idiopathic Arthritis. Current Rheumatology Reviews 2021; 17(1): 41 doi: 10.2174/1573403X16999200917151805
|
| 10 |
Tatyana P. Makalish, Ilya O. Golovkin, Volodymyr V. Oberemok, Kateryna V. Laikova, Zenure Z. Temirova, Olesya A. Serdyukova, Ilya A. Novikov, Roman A. Rosovskyi, Andrey I. Gordienko, Evgeniya Yu. Zyablitskaya, Elvina A. Gafarova, Kseniya A. Yurchenko, Iryna I. Fomochkina, Anatoly V. Kubyshkin. Anti-Rheumatic Effect of Antisense Oligonucleotide Cytos-11 Targeting TNF-α Expression. International Journal of Molecular Sciences 2021; 22(3): 1022 doi: 10.3390/ijms22031022
|
| 11 |
Ingrid Becker, Gerd Horneff. Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry. Arthritis Care & Research 2017; 69(4): 552 doi: 10.1002/acr.22961
|
| 12 |
Lesia K. Dropulic, Howard M. Lederman. Diagnostic Microbiology of the Immunocompromised Host. 2016; : 1 doi: 10.1128/9781555819040.ch1
|
| 13 |
Karina Bonfiglioli. Cuidados para prescrição de biológicos: atualizações no rastreamento e seguimento com ênfase no risco infeccioso. Revista Paulista de Reumatologia 2017; (2017 jan-mar;16(1)): 6 doi: 10.46833/reumatologiasp.2017.16.1.6-9
|
| 14 |
Ramakant Singh, Vivek Vasdev, Satyam Bhatt, Ashwani Kumar, Abhishek Kumar, Kaushik Roy. Real-Life Experience of Safety Profile of a Rituximab Biosimilar (Reditux®) in Patients at a Rheumatology Center in India. Journal of Marine Medical Society 2024; 26(3): 386 doi: 10.4103/jmms.jmms_177_23
|
| 15 |
S. Piaserico, P. Dapavo, A. Conti, P. Gisondi, F.P. Russo. Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. Journal of the European Academy of Dermatology and Venereology 2017; 31(11): 1853 doi: 10.1111/jdv.14146
|
| 16 |
C. Papeix, C. Donze, C. Lebrun-Frénay, C. Papeix, C. Donzé, C. Lebrun-Frénay, D. Laplaud, E. Thouvenot, X. Ayrignac, V. Pourcher-Martinez, H. Zéphir, J. de Seze, L. Michel, C. Bensa, C. Cara-Dalliere, A.M. Guen-noc, O. Casez, A. Maarouf, B. Bourre, A. Kwiatkowski, M. Cohen, E. Maillart, N. Collongues, C. Louapre, G. Androdias, A. Guegen, B. Audoin, G. Mattey, P. Bernady, J.M. Faucheux, P. Labauge, C. Meckies, B. Stankoff, P. Tourniaire, A. Dinh, A.M. Guennoc, F. Durnad-Dubief, S. Wiertlewski, N. Derache, E. Le page, S. Pittion, S. Vukusic, P. Clavelou, O. Heinzlef, R. Colamarino, E. Planque, A. Rico, C. Sheiber nogueira, M. de Seze, J. Ciron, H. Alchaar, D. Bensmail, D. Biotti, P. Branger, B. Brochet, B. Castan, A. Creange, E. Creisson, T. DeBroucker, R. Depaz, X. Douay, C. Dulau, M. Faucher, M. Fournier, A. Fromont, P. Gallien, O. Gout, J. Grimaud, Y. Hervé, A. Kerbrat, L. Kremer, L. Lanotte, L. Magy, A. Mania, A. Maurousset, X. Moisset, A. Montcuquet, T. Moreau, N. Morel, I. Patry, D. Peaureaux, M.C. Pouget, A. Ruet, C. Saint-Val, J.P. Stahl, F. Taithe, P. Tattevin, M. Vaillant, F. Vuoto. Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society. Revue Neurologique 2021; 177(8): 980 doi: 10.1016/j.neurol.2021.04.011
|
| 17 |
Ivan Noreña, Mario Fernández-Ruiz, José María Aguado. Viral infections in the biologic therapy era. Expert Review of Anti-infective Therapy 2018; 16(10): 781 doi: 10.1080/14787210.2018.1521270
|
| 18 |
Yasuhiro Otaki, Makiko DaSilva Ishida, Yuichi Saito, Yasuaki Oyama, Giichiro Oiso, Mitsuru Moriyama. Analysis of Closed Claims in the Clinical Management of Rheumatoid Arthritis in Japan. Chinese Medical Journal 2017; 130(12): 1454 doi: 10.4103/0366-6999.207479
|
| 19 |
C. Iking-Konert, W.-J. Mayet, S. Kuchen, J. Jenewein, S. Büchi, H. Zeidler, B. Michel. Differenzialdiagnose rheumatischer Erkrankungen. 2019; : 363 doi: 10.1007/978-3-662-56575-9_10
|
| 20 |
Marcia A. Friedman, Kevin L. Winthrop. Vaccines and Disease-Modifying Antirheumatic Drugs. Rheumatic Disease Clinics of North America 2017; 43(1): 1 doi: 10.1016/j.rdc.2016.09.003
|
| 21 |
Ying-Ming Chiu, Der-Yuan Chen. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics. Expert Review of Clinical Immunology 2020; 16(2): 207 doi: 10.1080/1744666X.2019.1705785
|
| 22 |
Arman Zakaryan, Knarik Ginosyan. Perioperative Management of Patients With Ankylosing Spondylitis Undergoing Spine Surgery. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01017
|
| 23 |
Turki Alameel, Eman Al Sulais. Risk of HBV Reactivation Among IBD patients With Occult Hepatitis B Virus Infection. Clinical Gastroenterology and Hepatology 2021; 19(3): 621 doi: 10.1016/j.cgh.2020.04.089
|
| 24 |
Benjamin Chaigne, Hervé Watier. Theranostic of biopharmaceuticals. Pharmacology & Therapeutics 2017; 175: 67 doi: 10.1016/j.pharmthera.2017.02.035
|
| 25 |
Florian Thalhammer. Biologika und Infektionen. rheuma plus 2016; 15(2): 42 doi: 10.1007/s12688-016-0066-2
|
| 26 |
Padmanabha Shenoy, Kaveri K. Nalianda. Handbook of Biologics for Rheumatological Disorders. 2022; : 199 doi: 10.1007/978-981-16-7200-2_19
|
| 27 |
Joe Sasadeusz, Andrew Grigg, Peter D. Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G. Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G. Gish, Kumar Visvanathan. Screening and Prophylaxis to Prevent Hepatitis B Reactivation. Clinics in Liver Disease 2019; 23(3): 521 doi: 10.1016/j.cld.2019.04.012
|
| 28 |
Marco Biolato, Assunta Bianco, Matteo Lucchini, Antonio Gasbarrini, Massimiliano Mirabella, Antonio Grieco. The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review. CNS Drugs 2021; 35(8): 861 doi: 10.1007/s40263-021-00842-9
|
| 29 |
Masayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, Tsu-Yi Hsieh, Yi-Ming Chen, Josef S Smolen, Gerd Burmester, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao, Mark C Genovese. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis. RMD Open 2020; 6(1): e001095 doi: 10.1136/rmdopen-2019-001095
|
| 30 |
Md Yuzaiful Md Yusof, Edward M. Vital, Maya H. Buch. B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use. Current Rheumatology Reports 2015; 17(10) doi: 10.1007/s11926-015-0539-7
|
| 31 |
Lesia K. Dropulic, Howard M. Lederman, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Overview of Infections in the Immunocompromised Host. Microbiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0026-2016
|
| 32 |
Maria R Ciardi, Marco Iannetta, Maria A Zingaropoli, Romina Salpini, Marianna Aragri, Rosanna Annecca, Simona Pontecorvo, Marta Altieri, Gianluca Russo, Valentina Svicher, Claudio M Mastroianni, Vincenzo Vullo. Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis. Open Forum Infectious Diseases 2019; 6(1) doi: 10.1093/ofid/ofy356
|
| 33 |
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host. 2016; : 69 doi: 10.1128/9781555819040.ch3
|
| 34 |
Stefano Piaserico, Andrea Conti, Ilaria Coati, Giovanna Galdo, Veronica Bernabucci, Andrea Zanca, Marina Drabeni, Flora Masutti, Maria L. Musumeci, Alfredo Alberti, Francesco P. Russo. Use of ustekinumab in five psoriatic patients with hepatitis B virus infection. Giornale Italiano di Dermatologia e Venereologia 2019; 154(3) doi: 10.23736/S0392-0488.17.05487-6
|
| 35 |
Matteo Megna, Cataldo Patruno, Maria Rita Bongiorno, Alessio Gambardella, Claudio Guarneri, Paolo Romita, Annunziata Raimondo, Francesco Loconsole, Gabriella Fabbrocini. Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection. Clinical Drug Investigation 2022; 42(6): 525 doi: 10.1007/s40261-022-01163-5
|
| 36 |
Mouhammad Kridin, Ofira Zloto, Khalaf Kridin, Arnon D. Cohen, Oran Mann, Orly Weinstein. The association of uveitis with hepatitis B and hepatitis C viruses: a large-scale population-based study. Eye 2023; 37(4): 720 doi: 10.1038/s41433-022-02037-y
|
| 37 |
Xinyi Wang, Jianyong Lei, Zhihui Li, Lunan Yan. Potential Effects of Coronaviruses on the Liver: An Update. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.651658
|
| 38 |
Jung Il Lee. Reactivation of Hepatitis B Virus in Patients with Rheumatologic Disease Treated with Biologic Disease Modifying Anti-rheumatic Drugs: Screening and Treatment. Journal of Rheumatic Diseases 2015; 22(5): 282 doi: 10.4078/jrd.2015.22.5.282
|
| 39 |
Takako Inoue, Takeshi Matsui, Yasuhito Tanaka. Novel strategies for the early diagnosis of hepatitis B virus reactivation. Hepatology Research 2021; 51(10): 1033 doi: 10.1111/hepr.13699
|
| 40 |
Josef S Smolen, Daniel Aletaha, Iain B McInnes. Rheumatoid arthritis. The Lancet 2016; 388(10055): 2023 doi: 10.1016/S0140-6736(16)30173-8
|
| 41 |
Melissa Padovan, Matteo Filippini, Angela Tincani, Elisabetta Lanciano, Eleonora Bruschi, Oscar Epis, Pietro Garau, Alessandro Mathieu, Eleonora Celletti, Leopoldo Giani, Paola Tomietto, Fabiola Atzeni, Piercarlo Sarzi Puttini, Francesca Zuliani, Salvatore De Vita, Francesco Trotta, Anastasio Grilli, Massimo Puoti, Marcello Govoni. Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection. Arthritis Care & Research 2016; 68(6): 738 doi: 10.1002/acr.22786
|
| 42 |
Jean-Luc Davignon, Benjamin Rauwel, Yannick Degboé, Arnaud Constantin, Jean-Fredéric Boyer, Andrey Kruglov, Alain Cantagrel. Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review. Arthritis Research & Therapy 2018; 20(1) doi: 10.1186/s13075-018-1725-6
|
| 43 |
Barbara E. Ostrov, Daniel Amsterdam. Interplay of Anti-Viral Vaccines with Biologic Agents and Immunomodulators in Individuals with Autoimmune and Autoinflammatory Diseases. Immunological Investigations 2021; 50(7): 833 doi: 10.1080/08820139.2021.1900863
|
| 44 |
Florian MORETTO, François-Xavier CATHERINE, Clémentine ESTEVE, Mathieu BLOT, Lionel PIROTH. Isolated Anti-HBc: Significance and Management. Journal of Clinical Medicine 2020; 9(1): 202 doi: 10.3390/jcm9010202
|
| 45 |
Tatsuo Kanda, Shin Yasui, Masato Nakamura, Makoto Arai, Reina Sasaki, Yuki Haga, Shuang Wu, Shingo Nakamoto, Hiroaki Okamoto, Osamu Yokosuka. Recent Trend of Hepatitis E Virus Infection in Chiba Area, Japan: 3 of 5 Cases with Rheumatoid Arthritis. Case Reports in Gastroenterology 2015; 9(3): 317 doi: 10.1159/000441387
|
| 46 |
Manuel Pombo-Suarez, Juan J. Gomez-Reino. Infections in Systemic Autoimmune Diseases: Risk Factors and Management. Handbook of Systemic Autoimmune Diseases 2020; 16: 179 doi: 10.1016/B978-0-444-64217-2.00009-9
|
| 47 |
Chak Sing Lau, Faith Chia, Leonila Dans, Andrew Harrison, Tsu Yi Hsieh, Rahul Jain, Seung Min Jung, Mitsumasa Kishimoto, Ashok Kumar, Khai Pang Leong, Zhanguo Li, Juan Javier Lichauco, Worawit Louthrenoo, Shue Fen Luo, Rong Mu, Peter Nash, Chin Teck Ng, Bagus Suryana, Linda Kurniaty Wijaya, Swan Sim Yeap. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis. International Journal of Rheumatic Diseases 2019; 22(3): 357 doi: 10.1111/1756-185X.13513
|
| 48 |
Roberto Caporali, Gloria Crepaldi, Veronica Codullo, Francesca Benaglio, Sara Monti, Monica Todoerti, Carlomaurizio Montecucco. 20 years of experience with tumour necrosis factor inhibitors: what have we learned?. Rheumatology 2018; 57(Supplement_7): vii5 doi: 10.1093/rheumatology/key059
|
| 49 |
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and D. Microbiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
|
| 50 |
Christiane Gasperi, Olaf Stüve, Bernhard Hemmer. B cell-directed Therapies in Multiple Sclerosis. Neurodegenerative Disease Management 2016; 6(1): 37 doi: 10.2217/nmt.15.67
|
| 51 |
Yong Kwang Park, Eun-Sook Park, Doo Hyun Kim, Sung Hyun Ahn, Seung Hwa Park, Ah Ram Lee, Soree Park, Hong Seok Kang, Ji-Hyun Lee, Jong Man Kim, Suk-Koo Lee, Keo-Heun Lim, Nathalie Isorce, Shuping Tong, Fabien Zoulim, Kyun-Hwan Kim. Cleaved c-FLIP mediates the antiviral effect of TNF-α against hepatitis B virus by dysregulating hepatocyte nuclear factors. Journal of Hepatology 2016; 64(2): 268 doi: 10.1016/j.jhep.2015.09.012
|
| 52 |
Mariantonietta Pisaturo, Giovanni Di Caprio, Federica Calò, Federica Portunato, Salvatore Martini, Nicola Coppola. Management of HBV reactivation in non-oncological patients. Expert Review of Anti-infective Therapy 2018; 16(8): 611 doi: 10.1080/14787210.2018.1505501
|
| 53 |
Marcia A. Friedman, Kevin Winthrop. Vaccinations for rheumatoid arthritis. Current Opinion in Rheumatology 2016; 28(3): 330 doi: 10.1097/BOR.0000000000000281
|
| 54 |
Stephen Antwi, Daniel Oduro-Mensah, David Darko Obiri, Newman Osafo, Aaron Opoku Antwi, Helena Owusu Ansah, Augustine Ocloo, Laud K. N.-A. Okine. Hydro-ethanol extract of Holarrhena floribunda stem bark exhibits anti-anaphylactic and anti-oedematogenic effects in murine models of acute inflammation. BMC Complementary Medicine and Therapies 2022; 22(1) doi: 10.1186/s12906-022-03565-6
|
| 55 |
Marco Sebastiani, Fabiola Atzeni, Laura Milazzo, Luca Quartuccio, Carlo Scirè, Giovanni Battista Gaeta, Giovanni Lapadula, Orlando Armignacco, Marcello Tavio, Ignazio Olivieri, Pierluigi Meroni, Laura Bazzichi, Walter Grassi, Alessandro Mathieu, Claudio Mastroianni, Evangelista Sagnelli, Teresa Santantonio, Caterina Uberti Foppa, Massimo Puoti, Loredana Sarmati, Paolo Airò, Oscar Massimiliano Epis, Rossana Scrivo, Miriam Gargiulo, Agostino Riva, Andreina Manfredi, Giovanni Ciancio, Gianguglielmo Zehender, Gloria Taliani, Luca Meroni, Salvatore Sollima, Piercarlo Sarzi-Puttini, Massimo Galli. Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis. Joint Bone Spine 2017; 84(5): 525 doi: 10.1016/j.jbspin.2017.05.013
|
| 56 |
Ya-Chih Tien, Hsu-Heng Yen, Ching-Fang Li, Mei-Ping Liu, Yin-Tzu Hsue, Ming-Hui Hung, Ying-Ming Chiu. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study. Arthritis Research & Therapy 2018; 20(1) doi: 10.1186/s13075-018-1748-z
|